FR2281133A1 - Cyclopropylamides de peptide, leur preparation et leurs applications - Google Patents

Cyclopropylamides de peptide, leur preparation et leurs applications

Info

Publication number
FR2281133A1
FR2281133A1 FR7524954A FR7524954A FR2281133A1 FR 2281133 A1 FR2281133 A1 FR 2281133A1 FR 7524954 A FR7524954 A FR 7524954A FR 7524954 A FR7524954 A FR 7524954A FR 2281133 A1 FR2281133 A1 FR 2281133A1
Authority
FR
France
Prior art keywords
hypophysaric
hypothalamic
origin
male
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7524954A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2281133A1 publication Critical patent/FR2281133A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069Ser-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR7524954A 1974-08-09 1975-08-11 Cyclopropylamides de peptide, leur preparation et leurs applications Withdrawn FR2281133A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438352A DE2438352A1 (de) 1974-08-09 1974-08-09 Peptidcyclopropylamide mit lh-rh/fshrh-wirkung

Publications (1)

Publication Number Publication Date
FR2281133A1 true FR2281133A1 (fr) 1976-03-05

Family

ID=5922834

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7524954A Withdrawn FR2281133A1 (fr) 1974-08-09 1975-08-11 Cyclopropylamides de peptide, leur preparation et leurs applications

Country Status (10)

Country Link
JP (1) JPS5141359A (enrdf_load_stackoverflow)
AU (1) AU8374575A (enrdf_load_stackoverflow)
BE (1) BE832311A (enrdf_load_stackoverflow)
DE (1) DE2438352A1 (enrdf_load_stackoverflow)
DK (1) DK361375A (enrdf_load_stackoverflow)
FR (1) FR2281133A1 (enrdf_load_stackoverflow)
IL (1) IL47879A0 (enrdf_load_stackoverflow)
LU (1) LU73168A1 (enrdf_load_stackoverflow)
NL (1) NL7509259A (enrdf_load_stackoverflow)
SE (1) SE7508927L (enrdf_load_stackoverflow)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59194069U (ja) * 1983-06-08 1984-12-24 大日本印刷株式会社 尿検査用カツプ
JPS6041859U (ja) * 1983-08-29 1985-03-25 栄研化学株式会社 血液診断用分析試験片
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
EP1444988A4 (en) 2001-11-13 2007-04-25 Takeda Pharmaceutical CANCER AGENT
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
DK1575569T3 (da) 2002-12-13 2011-01-10 Durect Corp Oralt indgivelsessystem omfattende flydende bærematerialer med høj viskositet
PT2767292T (pt) 2004-09-17 2016-11-23 Durect Corp Composição anestésica local prolongada contendo aibs
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
PL2117521T3 (pl) 2006-11-03 2012-11-30 Durect Corp Transdermalne systemy dostarczania zawierające bupiwakainę
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
WO2014144975A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
SG11201811760VA (en) 2016-07-06 2019-01-30 Durect Corp Oral dosage form with drug composition, barrier layer and drug layer
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados

Also Published As

Publication number Publication date
DK361375A (da) 1976-02-10
BE832311A (fr) 1976-02-11
NL7509259A (nl) 1976-02-11
IL47879A0 (en) 1975-11-25
SE7508927L (sv) 1976-02-10
DE2438352A1 (de) 1976-02-26
JPS5141359A (enrdf_load_stackoverflow) 1976-04-07
LU73168A1 (enrdf_load_stackoverflow) 1977-04-13
AU8374575A (en) 1977-02-10

Similar Documents

Publication Publication Date Title
FR2281133A1 (fr) Cyclopropylamides de peptide, leur preparation et leurs applications
ATE221125T1 (de) Klonierte glutaminsäure-decarboxylase
AU7609687A (en) Agents for the treatment of arthroses
GB1523623A (en) Activity and process for their manufacture
BG101028A (en) Synthetic peptide analogs of lung surfactant protein sp-c
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
DK0720482T3 (da) Prosaposin og cytokin-afledte peptider som terapeutiske midler
ES528211A0 (es) Metodo de preparar derivados de vasotocina
KR900701832A (ko) 항-트롬빈
DE3261304D1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
GR852541B (enrdf_load_stackoverflow)
ES488382A1 (es) Procedimiento para la preparacion de lh-rh o de analogos de lh-rh
GB1146800A (en) Polypeptides
ES8507474A1 (es) Procedimiento para preparar ciclopeptidos
JPS56501648A (enrdf_load_stackoverflow)
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
DE3569541D1 (en) Pharmacologically active peptides
GB1536878A (en) Octapeptide
Mori et al. Physicochemical characterization of native and asialo human chorionic gonadotropin
EP0225746A3 (en) Therapeutic decapeptides
CA2102447A1 (en) Cyclopeptides
GB1437477A (en) Synthetic peptides
NZ335136A (en) Isolated peptides which complex with hla-cw*16 molecules, and uses thereof
EP0248231A3 (en) Pharmacologically active peptides
KR870010079A (ko) 면역촉진 활성을 갖는 트리펩티드

Legal Events

Date Code Title Description
ST Notification of lapse